Bessemer Group Inc Avrobio, Inc. Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 30, 2020
SELL
$10.08 - $27.21 $126,776 - $342,220
-12,577 Closed
0 $0
Q3 2019

Nov 07, 2019
SELL
$14.12 - $23.44 $114,301 - $189,746
-8,095 Reduced 39.16%
12,577 $178,000
Q2 2019

Jul 19, 2019
BUY
$13.21 - $27.29 $273,077 - $564,138
20,672 New
20,672 $336,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email